Trending...
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
- Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
Contract awarded for products that bring improvement to health care industry
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical announced its SafeBreak® Vascular has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company. The contract was awarded based on the recommendation of SafeBreak Vascular by hospital experts who serve on one of Vizient's member-led councils, and it signifies to Vizient members unique qualities that potentially bring improvement to the health care industry.
Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.
SafeBreak Vascular is the first of its kind Force-Activated Separation Device (FASD) on the market. SafeBreak is installed in the patient's IV line and separates when a harmful force is placed on an IV line, protecting the IV catheter. When it separates, valves on each side close to prevent the loss of blood and medication. In a large randomized controlled trial, SafeBreak reduced IV complications requiring an IV restart by 44%1. SafeBreak is the first FASD on the market to utilize this innovative approach of intentionally being the weak link in the IV line, giving clinicians the ability to address a long felt problem with a novel solution.
More on The PennZone
"We're thrilled to receive this Innovative Technology contract offering Vizient members easier access to SafeBreak Vascular and view this as further validation of the way it addresses the persistent problem of IV complications," said Vance Clement, CEO of Lineus Medical. "We believe integrating SafeBreak into clinical practice is a critical step towards Force-Activated Separation Devices becoming the standard of care for IV therapy," said Spencer Jones, Founder and Chief Technology Officer of Lineus Medical.
"Our member councils reviewed and determined SafeBreak Vascular should be recognized with an Innovative Technology contract based on its potential to make an incremental difference in health care," said Kelly Flaharty, director of contract process for Vizient. "Congratulations to Lineus Medical on receiving this contract status."
Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.
More on The PennZone
###
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more
at www.lineusmed.com and follow us on LinkedIn or Twitter.
1. Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2016; 38(3): 189-203.
MKG-0135 Rev. 00
Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program. Vizient member-led councils identify technologies that have the potential to enhance clinical care, patient safety, health care worker safety or improve business operations of health care organizations.
SafeBreak Vascular is the first of its kind Force-Activated Separation Device (FASD) on the market. SafeBreak is installed in the patient's IV line and separates when a harmful force is placed on an IV line, protecting the IV catheter. When it separates, valves on each side close to prevent the loss of blood and medication. In a large randomized controlled trial, SafeBreak reduced IV complications requiring an IV restart by 44%1. SafeBreak is the first FASD on the market to utilize this innovative approach of intentionally being the weak link in the IV line, giving clinicians the ability to address a long felt problem with a novel solution.
More on The PennZone
- Technology Leader and Army Veteran Releases Memoir on Late Autism Diagnosis
- Training Lofts Launches $1,099 Unlimited Training Membership Featuring Semi-Private Coaching, Nutrition Support, and Recovery Services
- God's Meal Barrel Announces Participation in Give Local York
- American Properties Realty, Inc. Leadership Attends NAHB International Builders' Show in Florida
- $317M Revenue and a Clear Path to $1B: $IQST is Positioned for a Major Profitability Inflection
"We're thrilled to receive this Innovative Technology contract offering Vizient members easier access to SafeBreak Vascular and view this as further validation of the way it addresses the persistent problem of IV complications," said Vance Clement, CEO of Lineus Medical. "We believe integrating SafeBreak into clinical practice is a critical step towards Force-Activated Separation Devices becoming the standard of care for IV therapy," said Spencer Jones, Founder and Chief Technology Officer of Lineus Medical.
"Our member councils reviewed and determined SafeBreak Vascular should be recognized with an Innovative Technology contract based on its potential to make an incremental difference in health care," said Kelly Flaharty, director of contract process for Vizient. "Congratulations to Lineus Medical on receiving this contract status."
Vizient represents a diverse membership base that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers and represents more than $100 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to health care. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.
More on The PennZone
- ASI Hosts 2026 Executive Business Summit for Global Partner Community
- Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
- Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
###
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced when a force-activated separation device is used. Learn more
at www.lineusmed.com and follow us on LinkedIn or Twitter.
1. Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2016; 38(3): 189-203.
MKG-0135 Rev. 00
Source: Lineus Medical
0 Comments
Latest on The PennZone
- NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
- Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
- Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
- Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
- Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
- Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
- From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
- Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
- Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
- Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
- South Philadelphia Filmmakers Launch Fourth Feature Film on Amazon Prime Video
- Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
- 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
- Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
- Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions
- Multi Location SEO Guide: Rank in Multiple Cities and Generate Consistent Leads
- Raleigh Emerges as a Key Player in Sustainable Fashion Innovation for 2026
- Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
- 13 Full Moons of Black Dandelion Convergent Voice™ An Integration of Literacy & Wellness Symposium
- Yoga Retreats, Ecstatic Dance & Spiritual App launched
